Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Akebia Therapeutics Inc (NASDAQ: AKBA) closed at $1.91 in the last session, down -1.04% from day before closing price of $1.93. In other words, the price has decreased by -$1.04 from its previous closing price. On the day, 3.57 million shares were traded. AKBA stock price reached its highest trading level at $1.94 during the session, while it also had its lowest trading level at $1.88.
Ratios:
We take a closer look at AKBA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.21 and its Current Ratio is at 1.41.
On August 28, 2023, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.75.
Piper Sandler Upgraded its Neutral to Overweight on May 31, 2023, whereas the target price for the stock was revised from $2 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Butler John P. sold 46,409 shares for $1.83 per share. The transaction valued at 84,928 led to the insider holds 2,557,921 shares of the business.
Burke Steven Keith sold 7,144 shares of AKBA for $13,074 on Mar 03 ’25. The SVP, Chief Medical Officer now owns 809,090 shares after completing the transaction at $1.83 per share. On Mar 03 ’25, another insider, Burke Steven Keith, who serves as the Officer of the company, bought 7,144 shares for $1.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKBA now has a Market Capitalization of 498951232 and an Enterprise Value of 588060288. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.11. Its current Enterprise Value per Revenue stands at 3.671 whereas that against EBITDA is -67.578.
Stock Price History:
The Beta on a monthly basis for AKBA is 0.87, which has changed by 0.17177916 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, AKBA has reached a high of $2.89, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -7.96%, while the 200-Day Moving Average is calculated to be 15.69%.
Shares Statistics:
According to the various share statistics, AKBA traded on average about 3.46M shares per day over the past 3-months and 7608040 shares per day over the past 10 days. A total of 261.23M shares are outstanding, with a floating share count of 250.51M. Insiders hold about 4.10% of the company’s shares, while institutions hold 23.98% stake in the company. Shares short for AKBA as of 1741910400 were 16570902 with a Short Ratio of 4.80, compared to 1739491200 on 14981253. Therefore, it implies a Short% of Shares Outstanding of 16570902 and a Short% of Float of 7.08.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
